Abstract for PubMed entry 18973295
Title Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes.
Authors J.Maksimoska, L.Feng, K.Harms, C.Yi, J.Kissil, R.Marmorstein, E.Meggers.
Ref. J Am Chem Soc, 2008, 130, 15764-15765.
PubMed id 18973295
Abstract
A strategy for targeting protein kinases with large ATP-binding sites by using bulky and rigid octahedral ruthenium complexes as structural scaffolds is presented. A highly potent and selective GSK3 and Pim1 half-sandwich complex NP309 was successfully converted into a PAK1 inhibitor by making use of the large octahedral compounds Lambda-FL172 and Lambda-FL411 in which the cyclopentadienyl moiety of NP309 is replaced by a chloride and sterically demanding diimine ligands. A 1.65 A cocrystal structure of PAK1 with Lambda-FL172 reveals how the large coordination sphere of the ruthenium complex matches the size of the active site and serves as a yardstick to discriminate between otherwise closely related binding sites.